Galactorrhea and Pituitary Microadenoma in an 18-Year-Old Transfeminine Youth: A Case Report
AACE Endocrinology and Diabetes · 2026-03 · 13 (2) · 313-317
DOI: 10.1016/j.aed.2025.12.006 ↗Kurz gefasst
Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-03. Verfasst von Chansuda Bongsebandhu-Phubhakdi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- Center of Excellence in Transgender Health (CETH), Chulalongkorn University, Bangkok, Thailand.
- Department of Radiology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Zitieren
APA
Bongsebandhu-Phubhakdi, C., Jakchairoongruang, K., & Poonmaksatit, S. (2026). Galactorrhea and Pituitary Microadenoma in an 18-Year-Old Transfeminine Youth: A Case Report. AACE Endocrinology and Diabetes, 13(2), 313-317. https://doi.org/10.1016/j.aed.2025.12.006
Vancouver
Bongsebandhu-Phubhakdi C, Jakchairoongruang K, Poonmaksatit S. Galactorrhea and Pituitary Microadenoma in an 18-Year-Old Transfeminine Youth: A Case Report. AACE Endocrinology and Diabetes. 2026;13(2):313-317. doi:10.1016/j.aed.2025.12.006
BibTeX
@article{BongsebandhuPhubhakdi2026,
author = {Bongsebandhu-Phubhakdi, Chansuda and Jakchairoongruang, Ketsuda and Poonmaksatit, Sathida},
title = {Galactorrhea and Pituitary Microadenoma in an 18-Year-Old Transfeminine Youth: A Case Report},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
volume = {13},
number = {2},
pages = {313--317},
doi = {10.1016/j.aed.2025.12.006}
}
EUVIMED